Literature DB >> 6305636

Inhibition of stimulated bone resorption by vanadate.

N S Krieger, A H Tashjian.   

Abstract

We have previously reported that stimulated release of calcium (Ca) from bone is a sodium-dependent process. Partial support for this conclusion came from the observation that ouabain inhibited stimulated bone resorption as a result of inhibition of the Na,K-ATPase in bone. We now present additional supporting evidence from the results of experiments using vanadate, an ion known to inhibit the activity of Na,K-ATPase. Vanadate inhibited stimulated bone resorption in neonatal mouse calvaria. Inhibition occurred in a dose-dependent manner, and ortho-vanadate was 3-fold more potent than meta-vanadate. Ortho-vanadate was equally effective against several different stimulators of resorption, including PTH, prostaglandin E2, and 1,25-dihydroxycholecalciferol. PTH-stimulated bone resorption was inhibited with a Ki of about 9 microM. Stimulated Ca release was completely blocked whether vanadate was added at zero time or 24 h after the addition of a resorption-stimulating agent. Because the responses to vanadate were similar to those observed with ouabain, we conclude that vanadate is probably acting to inhibit stimulated resorption via inhibition of the Na,K-ATPase in bone.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6305636     DOI: 10.1210/endo-113-1-324

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  1 in total

1.  Protein-tyrosine phosphatase activity regulates osteoclast formation and function: inhibition by alendronate.

Authors:  A Schmidt; S J Rutledge; N Endo; E E Opas; H Tanaka; G Wesolowski; C T Leu; Z Huang; C Ramachandaran; S B Rodan; G A Rodan
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-02       Impact factor: 11.205

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.